- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02268916
Physical Activity and Participation
September 8, 2022 updated by: VA Office of Research and Development
Veterans With Diabetes Mellitus: Improving Physical Activity and Participation
The purpose of the study is to investigate if the investigators can improve physical activity and social participation level among Veterans with diabetes.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Physical activity is the cornerstone of good diabetes management, and yet effective physical activity intervention is not available.
The investigators developed a lifestyle intervention based on individual's home activity patterns.
The goal of the study is to test the efficacy of this intervention among Veterans with diabetes in a randomized-controlled trial.
In addition to physical activity, the investigators will also assess if the intervention will improve social participation among Veterans.
Study Type
Interventional
Enrollment (Actual)
104
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48105
- VA Ann Arbor Healthcare System, Ann Arbor, MI
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
56 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Veterans
- Aged 60 years or older
- Has Type 2 diabetes mellitus
- Able to operate accelerometer
- Competent to consent to the study
- No dementia diagnosis
- Ambulatory with or without assistive device
- English-speaking
- Community living (i.e., not a nursing home resident)
- Not physically active on a regular basis (less than 150 minutes of moderate or vigorous physical activity per week)
Exclusion Criteria:
- Medically unstable
- Hospitalized within the last 6 months
- 2 or more days of complete bed rest in the last month
- hemiplegia or limb amputation
- Self-reported illness or conditions that would impair the cooperation with the study team or the ability to complete the study
- work involved in shift schedule
- current enrollment of a physical activity program
- replacement of hip or knee within the last 6 months.
- Parkinson's disease
- frequent falls
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention
OT-led counseling based on home activity pattern
|
OT led counseling
|
|
Placebo Comparator: Wait-listed
Usual activity during the study.
At the end of the study, will receive OT-led counseling
|
At the end of the study, will receive OT-led counseling
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Physical Activity
Time Frame: 6 months
|
Home physical activity changes from baseline to 6-months.Physical activity was measured using a validated survey called CHAMPS, asking the participants to report activities that they participated in a typical week, such as walking, doing house work, dancing, etc.
|
6 months
|
|
Social Participation
Time Frame: 6 months
|
Survey questionnaires of participation change from baseline to 6-months follow up, specifically, satisfaction with participation in social roles, satisfaction with participation in discretionary social activities, and ability to participate in social roles and activities.
Each survey has been validated and scored on the T-score metrics.
A T-score is a standardized score, and has a "middle" score; it is 50 for T-scores.
This middle score is the mean of a large sample that is representative of the US general population.
The survey results are T-score metrics in which 50 is the mean score of the general population and 10 is the standard deviation (SD) of that population.
The study outcomes are changes in T-scores of each survey from baseline to 6-months follow-up, where positive score means improved outcome, and negative score means worse outcome at 6-months.
|
6 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Physical Function
Time Frame: 6 months
|
Six month changes in timed up and go test, where the participant get up from sitting in a chair, walk meters, turn around, and walk back to sit down.
Positive changes means worse outcome for timed up and go (seconds).
|
6 months
|
|
Physical Function
Time Frame: 6 months
|
Six month changes in gait speed, which is the comfortable gait peed in 10 meter walking.
Positive changes means better outcomes for gait speed (meters per second).
|
6 months
|
|
Physical Function
Time Frame: 6 months
|
Six month changes in six-minute walk test, which measures the distance a participant walked at usual pace for six minutes.
Positive changes means better outcomes for six-minute walk (meters).
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Pearl G. Lee, MD, VA Ann Arbor Healthcare System, Ann Arbor, MI
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2015
Primary Completion (Actual)
December 31, 2019
Study Completion (Actual)
December 31, 2019
Study Registration Dates
First Submitted
October 15, 2014
First Submitted That Met QC Criteria
October 15, 2014
First Posted (Estimate)
October 20, 2014
Study Record Updates
Last Update Posted (Actual)
September 19, 2022
Last Update Submitted That Met QC Criteria
September 8, 2022
Last Verified
September 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- O1190-W
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 2 Diabetes Mellitus
-
University of North Carolina, Chapel HillAmerican Heart AssociationRecruitingType 2 Diabetes | Nutrition | Diabetes Type 2 | T2DM (Type 2 Diabetes Mellitus) | Diabetes Mellitis | T2DM | Diabetes EducationUnited States
-
ENBIOSIS BIOTECHNOLOGIESAydin Adnan Menderes University; Izmir University of Economics; Buca Seyfi Demirsoy... and other collaboratorsNot yet recruitingType 2 Diabetes | Diabetes Mellitus Type 2Turkey (Türkiye)
-
Instituto Nacional de Ciencias Medicas y Nutricion...Active, not recruiting
-
Endogenex, Inc.Not yet recruitingDiabetes Mellitus, Type 2 | Diabetes | Type 2 Diabetes Mellitus | Type 2 Diabetes | Type2diabetes
-
Endogenex, Inc.Not yet recruitingDiabetes Mellitus, Type 2 | Diabetes | Type 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type2Diabetes
-
University of Colorado, DenverMassachusetts General Hospital; Ann & Robert H Lurie Children's Hospital of... and other collaboratorsRecruitingDiabetes Mellitus | Diabetes | Type 2 Diabetes | Diabetes Mellitus Type 2 | Diabetes Mellitus, Type I | Diabetes Mellitus Type II | Diabetes Mellitus, Insulin-Dependent | Diabetes, Autoimmune | Type 1 Diabetes (T1D) | Diabetes Type 2 on Insulin | Diabetes, Type IIUnited States
-
University of SalamancaUniversity of Salamanca; Instituto Piaget; Escola Superior de Tecnologia da Saúde...Enrolling by invitationType 2 Diabetes Mellitus | Aging | Hyperglycemia Due to Type 2 Diabetes MellitusPortugal
-
Kaiser PermanenteThe Permanente Medical GroupEnrolling by invitationType 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type 2 Diabetes (T2D)United States
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Steno Diabetes Center CopenhagenRecruitingDiabetes | Cognitive Impairment | Type 2 Diabetes | Diabetes Mellitus Type 2 | Cognitive Decline | Type 2 Diabetes Mellitus (T2DM)Denmark
Clinical Trials on Counseling
-
Tri-Service General HospitalCompletedLung Cancer PatientsTaiwan
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedMalignant NeoplasmUnited States
-
Texas Christian UniversityTerminated
-
Lata Medical Research Foundation, NagpurUnknownMalnutrition in Pregnancy | Other Disorders of Breast and Lactation Associated With ChildbirthIndia
-
King Edward Medical UniversityActive, not recruitingCachexia; Cancer; SarcopeniaPakistan
-
David A KatzAmerican Heart AssociationCompleted
-
Montefiore Medical CenterRecruiting
-
UKK InstituteFinnish Institute of Occupational Health; Academy of Finland; Vitalmed Research...CompletedEffects of Weight Reduction on Sleep and Alertness in Long-distance Truck and Bus Drivers (SF-Truck)Abdominal ObesityFinland
-
Federal University of São PauloUnknownPain | Myofascial Pain | Facial Pain | Therapeutic Exercise | Temporomandibular Disorder SyndromeBrazil
-
Port Said UniversityMansoura University; Prince Sattam Bin Abdulaziz UniversityRecruitingFertility IssuesEgypt